Class I phosphoinositide3-‐kinases in immunity…
121
108. Bartok, B.; Boyle, D. L.; Liu, Y.; Ren, P.; Ball, S. T.; Bugbee, W. D.; Rommel, C.; & al. PI3
kinase
δ
is a key regulator of synoviocyte function in rheumatoid arthritis.
Amer J Pathol
180
, 1906-‐1916(2012).
109. Vinuesa, C. G.; Cook,M. C.; Angelucci, C.; Athanasopoulos, V.; Rui, L.; Hill, K.M.; Yu, D.; &al.
A RING-‐type ubiquitin ligase family member required to repress follicular helper T cells
andautoimmunity.
Nature
435
, 452-‐458(2005).
110. Yu, D.; Tan, A. H.-‐M.; Hu, X.; Athanasopoulos, V.; Simpson, N.; Silva, D. G.; Hutloff, A.; & al.
Roquinrepresses autoimmunityby limiting inducibleT-‐cell co-‐stimulatormessengerRNA.
Nature
450
, 299-‐303(2007).
111. Lee, S. K.; Silva, DiegoG.; Martin, JaimeL.; Pratama, A.; Hu, X.; Chang, P.-‐P.;Walters, G.; &
al. Interferon-‐
γ
excess leads to pathogenic accumulation of follicular helper T cells and
germinal centers.
Immunity
37
, 880-‐892(2012).
112. Sweet, R. A.; Lee, S. K.;&Vinuesa, C. G. Developing connectionsamongst keycytokines and
dysregulatedgerminal centers inautoimmunity.
CurrOpin Immunol
24
, 658-‐664(2012).
113. Barber, D. F.; Bartolome, A.; Hernandez, C.; Flores, J. M.; Redondo, C.; Fernandez-‐Arias, C.;
Camps, M.; & al. PI3Kg inhibition blocks glomerulonephritis and extends lifespan in a
mousemodel of systemic lupus.
NatMedicine
11
, 933-‐935(2005).
114. Barber, D. F.; Bartolome, A.; Hernandez, C.; Flores, J. M.; Fernandez-‐Arias, C.; Rodriguez-‐
Borlado, L.; Hirsch, E.; & al. Class IB-‐phosphatidylinositol 3-‐kinase (PI3K) deficiency
ameliorates IA-‐PI3K-‐induced systemic lupus but not T cell invasion.
J Immunol
176
, 589-‐
593(2006).
115. Suárez-‐Fueyo, A.; Barber, D. F.; Martínez-‐Ara, J.; Zea-‐Mendoza, A. C.; & Carrera, A. C.
Enhanced phosphoinositide 3-‐kinase
δ
activity is a frequent event in Systemic Lupus
Erythematosus that confers resistance to activation-‐induced T cell death.
J Immunol
187
,
2376-‐2385(2011).
116.Maxwell,M. J.; Tsantikos, E.; Kong, A.M.; Vanhaesebroeck, B.; Tarlinton, D.M.; &Hibbs,M.
L. Attenuation of phosphoinositide 3-‐kinase
δ
signaling restrains autoimmune disease.
J
Autoimmun
38
, 381-‐391(2012).
117. Acosta, Y. Y.;Montes-‐Casado,M.; Aragoneses-‐Fenoll, L.; Dianzani, U.; Portolés, P.; &Rojo, J.
M. Suppression of CD4
+
T lymphocyte activation “in vitro” and experimental
encephalomyelitis “in vivo” by the phosphatidyl inositol 3-‐kinase inhibitor PIK-‐75.
Int J
Immunopathol Pharmacol
MS1814
, (Enviado) (2013).
118. Dagia, N. M.; Agarwal, G.; Kamath, D. V.; Chetrapal-‐Kunwar, A.; Gupte, R. D.; Jadhav, M. G.;
Dadarkar, S. S.; & al. A preferential p110
α/γ
PI3K inhibitor attenuates experimental
inflammation by suppressing the production of proinflammatory mediators in a NF-‐
κ
B-‐
dependentmanner.
AmJ Physiol Cell Physiol
298
, C929-‐941(2010).
119. Roller, A.; Perino, A.; Dapavo, P.; Soro, E.; Okkenhaug, K.; Hirsch, E.; & Ji, H. Blockade of
phosphatidylinositol 3-‐kinase (PI3K)δ or PI3Kγ reduces IL-‐17 and ameliorates
Imiquimod-‐inducedpsoriasis-‐likedermatitis
J Immunol
189
, 4612-‐4620(2012).
120. Schreiber, R. D.; Old, L. J.; & Smyth, M. J. Cancer immunoediting: Integrating immunity's
roles incancer suppressionandpromotion.
Science
331
, 1565-‐1570(2011).
121. Vesely, M. D.; Kershaw, M. H.; Schreiber, R. D.; &Smyth, M. J. Natural innate and adaptive
immunity tocancer.
AnnuRev Immunol
29
, 235-‐271(2011).
122. Zou,W.; &Chen, L. Inhibitory B7-‐familymolecules in the tumourmicroenvironment.
Nat
Rev Immunol
8
, 467-‐477(2008).
123. Strauss, L.; Bergmann, C.; Szczepanski, M. J.; Lang, S.; Kirkwood, J. M.; &Whiteside, T. L.
Expression of ICOS on human melanoma-‐infiltrating CD4
+
CD25
high
Foxp3
+
T regulatory
cells: Implications and impact on tumor-‐mediated immune suppression.
J Immunol
180
,
2967-‐2980(2008).
124. Chen, X. L.; Cao, X. D.; Kang, A. J.;Wang, K.M.; Su, B. S.;&Wang, Y. L. Insituexpressionand
significance of B7 costimulatory molecules within tissues of human gastric carcinoma.
World J Gastroenterol
9
, 1370-‐1373(2003).
125.Martin-‐Orozco, N.; Li, Y.;Wang, Y.; Liu, S.; Hwu, P.; Liu, Y.-‐J.; Dong, C.; &al.Melanoma cells
express ICOS ligand to promote the activation and expansion of T-‐regulatory cells.
Cancer
Res
70
, 9581-‐9590(2010).
126. Conrad, C.; & Gilliet, M. Plasmacytoid dendritic cells and regulatory T cells in the tumor
microenvironment: Adangerous liaison.
Oncoimmunology
2
, e23887(2013).
